FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

tudor ciuleanu

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Ioana Berindan-Neagoe; Cornelia Braicu; Ovidiu Balacescu; Roxana Cojocneanu Petric; Dana Iancu; Nicolae Miron; Valentina Pileczki; tudor ciuleanu
5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells.
Bjørn H Grønberg; Marjo Hahka-Kemppinen; Aija Knuuttila; Kurt Krejcy; Seppo W Langer; Astra M Liepa; Maria Munoz; Edvard Abel; tudor ciuleanu; Øystein Fløtten; Stein Sundstrøm
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer.
Vassilis Golfinopoulos; Ann C Goussia; D Krikelis; Vassiliki Malamou-Mitsi; Marios Marselos; Mattheos Bobos; A Cervantes; tudor ciuleanu; George Fountzilas; George Pentheroudakis; V Siozopoulou; Nicholas Pavlidis
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of tudor ciuleanu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ioana Berindan-Neagoe; Cornelia Braicu; Ovidiu Balacescu; Roxana Cojocneanu Petric; Dana Iancu; Nicolae Miron; Valentina Pileczki; tudor ciuleanu
5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells.
Journal of gastrointestinal and liver diseases : JGLD 2013;22(1):37-43.
2012: Bjørn H Grønberg; Marjo Hahka-Kemppinen; Aija Knuuttila; Kurt Krejcy; Seppo W Langer; Astra M Liepa; Maria Munoz; Edvard Abel; tudor ciuleanu; Øystein Fløtten; Stein Sundstrøm
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;78(1):63-9.
2012: Vassilis Golfinopoulos; Ann C Goussia; D Krikelis; Vassiliki Malamou-Mitsi; Marios Marselos; Mattheos Bobos; A Cervantes; tudor ciuleanu; George Fountzilas; George Pentheroudakis; V Siozopoulou; Nicholas Pavlidis
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2725-30.
2012: George R Blumenschein; Richard C Chao; tudor ciuleanu; Harry J M Groen; Francisco Robert; Ana Ruiz-Garcia; Lesley Tye; Tiziana Usari; Erzsebet Juhasz
Sunitinib plus erlotinib for the treatment of advanced/metastatic non-small-cell lung cancer: a lead-in study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(9):1406-16.
2012: Dimitrios Krikelis; Vassiliki Malamou-Mitsi; Mattheos Bobos; Andres Cervantes; tudor ciuleanu; George Fountzilas; Vassilis Golfinopoulos; Ann C Goussia; George Pentheroudakis; Dimitrios Petrakis; Vassiliki Siozopoulou; Aikaterini Stoyianni; Nicholas Pavlidis
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.
Clinical & experimental metastasis 2012;29(6):603-14.
2012: Egbert F Smit; M A Socinski; Aleksandra Szczesna; Joachim von Pawel; tudor ciuleanu; S C Guba; S Hong; R R Hozak; N A Karaseva; P Lorigan; B P Mullaney; S P Myrand; D Ohannesian; E Powell; Martin Reck; Giorgio V Scagliotti; N Thatcher
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1723-9.
2012: T Brodowicz; tudor ciuleanu; J Crawford; M Filipits; J R Fischer; V Georgoulias; C Gridelli; F R Hirsch; J Jassem; P Kosmidis; M Krzakowski; Ch Manegold; C Minichsdorfer; R Pirker; J L Pujol; R Stahel; N Thatcher; J Vansteenkiste; C C Zielinski; Sabine Zöchbauer-Müller
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(5):1223-9.
2012: tudor ciuleanu; Saulius Cicenas; Alexandru Calin Grigorescu; Carina Hillenbach; Hrefna Kristin Johannsdottir; Barbara Klughammer; Skaidrius Miliauskas; Lilia Stelmakh; Emilio Esteban Gonzalez
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
The lancet oncology 2012;13(3):300-8.
2012: Eduard Vrdoljak; tudor ciuleanu; Galina Kharkevich; J Mardiak; Michal Mego; Peeter Padrik; Luboš Petruželka; Gunta Purkalne; Yaroslav Shparyk; Breda Skrbinc; Cezary Szczylik; Laszlo Torday
Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.
Expert opinion on pharmacotherapy 2012;13(2):159-74.
2012: George Fountzilas; Anna Kalogera-Fountzila; Georgia Karayannopoulou; Konstantinos Markou; Despina Misailidou; Angelos Nikolaou; L Resiga; Epaminondas Samantas; Dimosthenis Skarlos; Thomas Zaramboukas; Helen Athanassiou; Mattheos Bobos; E Ciuleanu; D Dionysopoulos; A G Eleftheraki; tudor ciuleanu
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):427-35.
2011: Cécile Le Péchoux; D Lerouge; Elisabeth Quoix; Suresh Senan; G M Videtic; Rinus Wanders; Aaron H Wolfson; Rodrigo Arriagada; tudor ciuleanu; Ariane Dunant; Corinne Faivre-Finn; M Hatton; R Jones; R Keus; Agnès Laplanche
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(5):1154-63.
2010: Markus M Heiss; Pawel Murawa; Piotr Koralewski; Elzbieta Kutarska; Olena O Kolesnik; Vladimir V Ivanchenko; Alexander S Dudnichenko; Birute Aleknaviciene; Arturas Razbadauskas; Martin Gore; Elena Ganea-Motan; tudor ciuleanu; Pauline Wimberger; Alexander Schmittel; Barbara Schmalfeldt; Alexander Burges; Carsten Bokemeyer; Horst Lindhofer; Angelika Lahr; Simon L Parsons
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
International journal of cancer. Journal international du cancer 2010;127(9):2209-21.
2010: Federico Cappuzzo; tudor ciuleanu; Lilia Stelmakh; Saulius Cicenas; Aleksandra Szczésna; Erzsébet Juhász; Emilio Esteban; Olivier Molinier; Wolfram Brugger; Ivan Melezínek; Gaëlle Klingelschmitt; Barbara Klughammer; Giuseppe Giaccone
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.
The lancet oncology 2010;11(6):521-9.
2009: tudor ciuleanu; Thomas Brodowicz; Christoph Zielinski; Joo-Hang Kim; Maciej Krzakowski; Eckart Laack; Yi-Long Wu; Isabel Bover; Stephen Begbie; Valentina Tzekova; Branka Cucevic; Jose Rodrigues Pereira; Sung Hyun Yang; Jayaprakash Madhavan; Katherine P Sugarman; Patrick Peterson; William J John; Kurt Krejcy; Chandra P Belani
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
Lancet 2009;374(9699):1432-40.
2009: Mark A Socinski; Egbert F Smit; Paul Lorigan; Kartik Konduri; Martin Reck; Aleksandra Szczesna; Johnetta Blakely; Piotr Serwatowski; Nina A Karaseva; tudor ciuleanu; Jacek Jassem; Mircea Dediu; Shengyan Hong; Carla Visseren-Grul; Axel-Rainer Hanauske; Coleman K Obasaju; Susan C Guba; Nick Thatcher
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4787-92.
2009: Pol M Specenier; tudor ciuleanu; Jane E Latz; Luna C Musib; Christelle L S Darstein; Jan B Vermorken
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
Cancer chemotherapy and pharmacology 2009;64(2):233-41.
2009: Ulrich Gatzemeier; tudor ciuleanu; Mircea Dediu; Elena Ganea-Motan; Heinz Lubenau; Auro Del Giglio
XM02, the first biosimilar G-CSF, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with small cell or non-small cell lung cancer receiving platinum-based chemotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(6):736-40.
2009: tudor ciuleanu; Alexander V Pavlovsky; Gyorgy Bodoky; Avgust M Garin; Virginia K Langmuir; Stewart Kroll; George T Tidmarsh
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
European journal of cancer (Oxford, England : 1990) 2009;45(9):1589-96.
2009: Cécile Le Péchoux; Ariane Dunant; Suresh Senan; Aaron H Wolfson; Elisabeth Quoix; Corinne Faivre-Finn; tudor ciuleanu; Rodrigo Arriagada; Richard Jones; Rinus Wanders; Delphine Lerouge; Agnès Laplanche
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
The lancet oncology 2009;10(5):467-74.
2008: Corey J Langer; Kenneth J O'Byrne; Mark A Socinski; Sergei M Mikhailov; Krzysztof Leśniewski-Kmak; Martin Smakal; tudor ciuleanu; Sergey V Orlov; Mircea Dediu; David Heigener; Amy J Eisenfeld; Larissa Sandalic; Fred B Oldham; jack w singer; Helen J Ross
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(6):623-30.
2008: Robert E. Smith; Matti S Aapro; Heinz Ludwig; Tamás Pintér; Martin Smakal; tudor ciuleanu; Li Chen; Tom Lillie; John A Glaspy
Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1040-50.
2008: E Ciuleanu; A Irimie; tudor ciuleanu; V Popita; N Todor; Nicolas Ghilezan
Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2008;13(1):37-42.
2007: Sorin Pripon; Sorin Pripon; tudor ciuleanu; Letitia I Radulescu
Malignant primary pulmonary tumor with hemangiopericytoma-like features: conventional hemangiopericytoma versus solitary fibrous tumor.
Clinical lung cancer 2007;8(8):504-8.
2007: Alexandru Grigorescu; tudor ciuleanu; Elena Firoiu; Delia Ruta Muresan; Gabriela Teodorescu; Bruce R Basson
A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2007;57(2):168-74.
2007: tudor ciuleanu; M Diculescu; Nicolas Hoepffner; J Trojan; V Sailer; Mark M Zalupski; T Herrmann; A Roth; Jon B Chick; K Brock; D Albert; Philip A Philip
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
Investigational new drugs 2007;25(4):385-90.
2007: Sorin Pripon; Sorin Pripon; Delia Bunea; tudor ciuleanu; Letitia I Radulescu
Endocrine paraneoplastic syndromes in small cell lung carcinoma. Two case reports.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12(3):411-4.
2007: Sorin Pripon; Sorin Pripon; A Parv; Caius Duncea; tudor ciuleanu; Letitia I Radulescu
Myocardial function in patients with breast cancer after therapy with anthracyclines and chest irradiation.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12(3):349-52.
2007: Sorin Pripon; Sorin Pripon; Andreea Parv; Caius Duncea; tudor ciuleanu
Altered left ventricular diastolic performance in oncologic patients treated with epirubicin.
Congestive heart failure (Greenwich, Conn.) 2007;13(4):215-20.
2007: P Rusu; tudor ciuleanu; D Cernea; D Pelau; V Gaal; C Cebotaru; T Guttman; N Todor; Nicolas Ghilezan
Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12(1):33-9.
2006: M E R O'Brien; tudor ciuleanu; Hristo Tsekov; Yaroslav Shparyk; Branka Cuceviá; Gabor Juhasz; Nicholas Thatcher; Graham A Ross; Graham C Dane; Theresa Crofts
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(34):5441-7.
2006: Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Wilbur A Franklin; Rafal Dziadziuszko; Nick Thatcher; ALEX CHANG; Purvish Parikh; Jose R Pereira; tudor ciuleanu; Joachim von Pawel; Claire Watkins; Angela Flannery; Gillian Ellison; Emma Donald; Lucy Knight; Dinah Parums; Nick Botwood; Brian Holloway
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5034-42.
2006: Thomas Brodowicz; Maciej Krzakowski; Matjaz Zwitter; Valentina Tzekova; Rodryg Ramlau; Nicolae Ghilezan; tudor ciuleanu; Branka Cucevic; Kálmán Gyurkovits; Ernst Ulsperger; Jacek Jassem; Mislav Grgic; Pinar Saip; Maria Szilasi; Christoph Wiltschke; Maria Wagnerova; Natalya Oskina; Victoria Soldatenkova; Christoph Zielinski; Miklos Wenczl
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):155-63.
2005: Nick Thatcher; ALEX CHANG; Purvish Parikh; José Rodrigues Pereira; tudor ciuleanu; Joachim von Pawel; Sumitra Thongprasert; Eng Huat Tan; Kristine Pemberton; Venice Archer; Kevin Carroll
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).
Lancet 2005;366(9496):1527-37.
2005: Frances A Shepherd; José Rodrigues Pereira; tudor ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Erlotinib in previously treated non-small-cell lung cancer.
The New England journal of medicine 2005;353(2):123-32.
2005: Sorin Pripon; Caius Duncea; tudor ciuleanu; Letitia I Radulescu; T Gal; I Cimpean
Does epirubicin affect left ventricular systolic performance in oncologic patients?
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):77-80.
2004: tudor ciuleanu; G Fountzilas; E Ciuleanu; M Plataniotis; N Todor; Nicolas Ghilezan
Paclitaxel and carboplatin in relapsed or metastatic nasopharyngeal carcinoma: a multicenter phase II study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2004;9(2):161-5.
2004: George Fountzilas; Elisabeta Ciuleanu; Urania Dafni; George Plataniotis; Anna Kalogera-Fountzila; Epaminondas Samantas; Eleni Athanassiou; John Tzitzikas; tudor ciuleanu; Angelos Nikolaou; Panayiotis Pantelakos; Thomas Zaraboukas; Nikolaos Zamboglou; John Daniilidis; Nicolas Ghilezan
Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study.
Medical oncology (Northwood, London, England) 2004;21(2):95-107.
2002: tudor ciuleanu; R Curcă; D Iancu; N Todor; C Cebotaru; I Radulescu; E Banu; Nicolas Ghilezan
First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. A phase II study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2002;7(1):43-6.